The estimated Net Worth of Daniel J. Lippis is at least $1.62 Milion dollars as of 11 July 2024. Daniel Lippis owns over 500 units of Edwards Lifesciences Corp stock worth over $1,616,774 and over the last few years Daniel sold EW stock worth over $0.
Daniel has made over 5 trades of the Edwards Lifesciences Corp stock since 2024, according to the Form 4 filled with the SEC. Most recently Daniel exercised 500 units of EW stock worth $22,640 on 11 July 2024.
The largest trade Daniel's ever made was exercising 1,715 units of Edwards Lifesciences Corp stock on 7 March 2024 worth over $63,026. On average, Daniel trades about 496 units every 14 days since 2024. As of 11 July 2024 Daniel still owns at least 23,689 units of Edwards Lifesciences Corp stock.
You can see the complete history of Daniel Lippis stock trades at the bottom of the page.
Daniel's mailing address filed with the SEC is ONE EDWARDS WAY, , IRVINE, CA, 92614.
Over the last 22 years, insiders at Edwards Lifesciences Corp have traded over $94,964,396 worth of Edwards Lifesciences Corp stock and bought 47,398 units worth $3,992,090 . The most active insiders traders include Michael A Mussallem, Donald E Jr Bobo oraz Steven R Loranger. On average, Edwards Lifesciences Corp executives and independent directors trade stock every 8 days with the average trade being worth of $1,126,057. The most recent stock trade was executed by Donald E Jr Bobo on 11 September 2024, trading 5,000 units of EW stock currently worth $226,400.
edwards lifesciences (nyse: ew) is the global leader in the science of heart valves and hemodynamic monitoring. driven by a passion to help patients, the company partners with clinicians to develop innovative technologies in the areas of structural heart disease and critical care monitoring that save and enhance lives. headquartered in irvine, california, edwards lifesciences has extensive operations in north america, europe, japan, latin america and asia and currently employs about 6,400 individuals worldwide. for us, helping patients is not a slogan – it's our life’s work. from developing devices that replace or repair a diseased heart valve to creating new technologies that monitor vital signs in the critical care setting, we help ensure that patients regain and even improve their quality of life.
Edwards Lifesciences Corp executives and other stock owners filed with the SEC include: